Hypertension Drug Market Explores New Growth Opportunities by Leading Manufacturers: Actelion, Novartis, Pfizer, Sanofi

Hypertension is a condition in which systolic blood pressure rises above 140 mmHg and diastolic blood pressure rises above 90 mmHg. The precise cause of hypertension is unknown; however, factors such as smoking, obesity, stress, excess sodium, old age, sleep apnea, certain hormonal conditions, kidney diseases, sedentary lifestyle, poor diet, lack of exercise and drugs and alcohol contribute to the incidence of hypertension.

According to the Centers for Disease Control and Prevention (CDC), hypertension was the leading cause of death for more than 410,000 Americans in 2014. Hypertension is a long-term disease and, therefore, it requires the daily administration of antihypertensive drugs, which are expected to lead to the hypertension market. In addition, R & D activities related to hypertension medicines are expected to present new opportunities during the prognosis period.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/2647?utm_source=openpr_ss

However, the expiration of patents for antihypertensive drugs, such as Benicar and Diovan, can hamper the growth of the market. In addition, strict government regulations, the adverse effects of these medications and the high cost of medical care leading to undiagnosed hypertension restrict the market.

The market is segmented according to type and geography. Depending on the type, the market is divided into diuretics, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, alpha-beta blockers, angiotensin II receptor blockers, aldosterone antagonists, calcium channel blockers, Renin inhibitors, alpha blockers, central action agents. , vasodilators, and others. Geographically, it is analyzed in North America, Europe, Asia-Pacific and LAMEA.

Send Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/2647?utm_source=openpr_ss

Major Market Players:

• Actelion Ltd.
• Novartis AG
• Pfizer Inc.
• Johnson &Johnson Ltd.
• Sanofi SA
• Lupin Limited

Key Benefits of Hypertension Drug Market:

• The study provides an in-depth analysis of the global Alprazolam powder market, with current trends and future estimates to elucidate investment pockets.

• It provides a comprehensive analysis of the factors that drive and restrict market growth.

• The report presents a quantitative analysis to help stakeholders capitalize on prevailing market opportunities.

• The extensive analysis of different segments facilitates the understanding of various products in the market.

• Key players are shaping up and their strategies are thoroughly analyzed to predict the competitive perspective of the market.

Browse More Details of Report @ https://www.alliedmarketresearch.com/hypertension-drug-market?utm_source=openpr_ss

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.